• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Medicines Transparency Kyrgyzstan
 

Medicines Transparency Kyrgyzstan

on

  • 1,974 views

Presentation on medicines transparency in Kyrgyzstan at the launch of the Medicines Transparency Alliance (MeTA) in London, May 2008

Presentation on medicines transparency in Kyrgyzstan at the launch of the Medicines Transparency Alliance (MeTA) in London, May 2008

Statistics

Views

Total Views
1,974
Views on SlideShare
1,974
Embed Views
0

Actions

Likes
0
Downloads
8
Comments
1

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel

11 of 1 previous next

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
  • After you got all the information on Fioricet, another point on your agenda should be the price for it. http://www.fioricetsupply.com resolves this problem. Now you can make the decision to buy.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Title of presentation 04/06/09 MeTA

Medicines Transparency Kyrgyzstan Medicines Transparency Kyrgyzstan Presentation Transcript

  • MeTA in Kyrgyzstan MeTA in Kyrgyzstan Mariam Djankorozova, MeTA Co-Director 16/05/2008
  • Agenda
    • Medicines Issues and Priorities in Kyrgyzstan
    • Past and Current Experience in Addressing Medicines Issues
    • Future Plans to Address Medicines Issues through MeTA
    • Intended outcomes
    16/05/2008
  • Overview: Medicines Issues and Priorities
    • Limited access to medicines
      • Limited affordability and availability
        • Especially important for chronic diseases highly prevalent in KG
        • Major problem in rural areas (70% population lives in rural areas)
          • 1 pharmacy:1500 people urban; 1 pharmacy:4500 people rural
    • Low Quality of Medicines
      • Counterfeit medicines from abroad; unable to fight against smuggled medicines
    • Limited access to reliable & timely information on medicines
      • Drug info. system under-developed, no info. on price, quality
    06/04/09
  • Limited access to medicines
    • Case of Hypertension
      • Several important and less expensive medicines (HCTZ) are not prescribed by doctors or recommended by pharmacists in favour of medicines that are highly promoted (enalapril)
        • Written prescription differs from oral directions given by doctor
        • People cannot afford expensive medicines; Insurance system insufficiently funded to adequately cover all beneficiaries
        • Preference for branded generics that are much more expensive
        • No mechanism to control promotion
      • MeTA offers a mechanism to provide information to counteract promotion; engage CSOs to reach public with information
    06/04/09
  • Low Quality of Medicines
    • Medicines entering country through official channels
      • 80 medicines per year are withdrawn due to poor quality
      • Currently no link between DRA and customs
    • Medicines entering country through informal channels
      • Major problem; mountainous country difficult to monitor;
      • Impossible to differentiate counterfeit from legitimate medicines
      • Sold to pharmacies at low prices;
      • Some are substandard (lower amount of active ingredient, some have no active ingredient)
    • MeTA offers opportunity to collect information and link activities between customs and DRA; disseminate information on quality of medicines in official and informal channels to consumers; CSOs can assist DRA to monitor and educate
    06/04/09
  • Limited access to reliable & timely information on medicines
    • Need information on:
      • Import, legislation, licensing, certification, registration, quality, price, procurement
    • MeTA can provide a mechanism for creating a single space on internet where all information can be accessible to all population (consumers and professionals); mobile phones may be an alternative to internet in rural areas; price monitoring will be key
      • Must be two-way communication with feedback from population, utilizing CSOs for outreach
    06/04/09
  • Summary
    • Kyrgyzstan has been a leader in the region in addressing pharmaceutical issues
      • One of the first countries to implement national drug policy, essential medicines list, standardized national treatment guidelines with training
      • Insurance system for medicines, projects to create networks of pharmacies in rural areas
    • Still, more work is needed; Ultimate goal is to improve access to medicines, especially for the poor
    • MeTA offers opportunity for government, private sector and civil society to work together and disclose information on medicines towards goals of increasing access to medicines
    06/04/09
  • Where to Get More Information
    • Department of Drug Provision and Medical Equipment
      • www.pharm.med.kg
    • Health Insurance Fund
      • www.foms.med.kg
    • Kyrgyz Republic National Health Care Reform Program
      • www.manastaalimi.med.kg/eng/
    06/04/09
  • Thank you!
    • Name of presenter: Mariam Djankorozova
    • Email: m_djankorozova@foms.med.kg
    • Mobile number: + 996 555 929412
    • International Secretariat, info@metasecretariat.org
    • MeTA: www.MedicinesTransparency.org
    • DFID: www.dfid.gov.uk
    06/04/09
  • Kyrgyzstan